These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

526 related items for PubMed ID: 28256010

  • 1. Striatal D1 medium spiny neuron activation induces dyskinesias in parkinsonian mice.
    Perez XA, Zhang D, Bordia T, Quik M.
    Mov Disord; 2017 Apr; 32(4):538-548. PubMed ID: 28256010
    [Abstract] [Full Text] [Related]

  • 2. L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice.
    Suárez LM, Solís O, Caramés JM, Taravini IR, Solís JM, Murer MG, Moratalla R.
    Biol Psychiatry; 2014 May 01; 75(9):711-22. PubMed ID: 23769604
    [Abstract] [Full Text] [Related]

  • 3. Striatal activation by optogenetics induces dyskinesias in the 6-hydroxydopamine rat model of Parkinson disease.
    F Hernández L, Castela I, Ruiz-DeDiego I, Obeso JA, Moratalla R.
    Mov Disord; 2017 Apr 01; 32(4):530-537. PubMed ID: 28256089
    [Abstract] [Full Text] [Related]

  • 4. Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation.
    Darmopil S, Martín AB, De Diego IR, Ares S, Moratalla R.
    Biol Psychiatry; 2009 Sep 15; 66(6):603-13. PubMed ID: 19520364
    [Abstract] [Full Text] [Related]

  • 5. ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice.
    Pavón N, Martín AB, Mendialdua A, Moratalla R.
    Biol Psychiatry; 2006 Jan 01; 59(1):64-74. PubMed ID: 16139809
    [Abstract] [Full Text] [Related]

  • 6. L-DOPA Oppositely Regulates Synaptic Strength and Spine Morphology in D1 and D2 Striatal Projection Neurons in Dyskinesia.
    Suarez LM, Solis O, Aguado C, Lujan R, Moratalla R.
    Cereb Cortex; 2016 Oct 17; 26(11):4253-4264. PubMed ID: 27613437
    [Abstract] [Full Text] [Related]

  • 7. Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activity.
    Paolone G, Brugnoli A, Arcuri L, Mercatelli D, Morari M.
    Mov Disord; 2015 Nov 17; 30(13):1728-38. PubMed ID: 26207892
    [Abstract] [Full Text] [Related]

  • 8. The Role of Primary Motor Cortex (M1) Glutamate and GABA Signaling in l-DOPA-Induced Dyskinesia in Parkinsonian Rats.
    Lindenbach D, Conti MM, Ostock CY, George JA, Goldenberg AA, Melikhov-Sosin M, Nuss EE, Bishop C.
    J Neurosci; 2016 Sep 21; 36(38):9873-87. PubMed ID: 27656025
    [Abstract] [Full Text] [Related]

  • 9. Loss of glutamic acid decarboxylase (Gad67) in striatal neurons expressing the Drdr1a dopamine receptor prevents L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned mice.
    Zhang K, Chammas C, Soghomonian JJ.
    Neuroscience; 2015 Sep 10; 303():586-94. PubMed ID: 26188284
    [Abstract] [Full Text] [Related]

  • 10. Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in mouse models.
    Thiele SL, Chen B, Lo C, Gertler TS, Warre R, Surmeier JD, Brotchie JM, Nash JE.
    Neurobiol Dis; 2014 Nov 10; 71():334-44. PubMed ID: 25171793
    [Abstract] [Full Text] [Related]

  • 11. L-DOPA activates ERK signaling and phosphorylates histone H3 in the striatonigral medium spiny neurons of hemiparkinsonian mice.
    Santini E, Alcacer C, Cacciatore S, Heiman M, Hervé D, Greengard P, Girault JA, Valjent E, Fisone G.
    J Neurochem; 2009 Feb 10; 108(3):621-33. PubMed ID: 19187092
    [Abstract] [Full Text] [Related]

  • 12. Implanted reuptake-deficient or wild-type dopaminergic neurons improve ON L-dopa dyskinesias without OFF-dyskinesias in a rat model of Parkinson's disease.
    Vinuela A, Hallett PJ, Reske-Nielsen C, Patterson M, Sotnikova TD, Caron MG, Gainetdinov RR, Isacson O.
    Brain; 2008 Dec 10; 131(Pt 12):3361-79. PubMed ID: 18988638
    [Abstract] [Full Text] [Related]

  • 13. CK2 Oppositely Modulates l-DOPA-Induced Dyskinesia via Striatal Projection Neurons Expressing D1 or D2 Receptors.
    Cortés M, Malave L, Castello J, Flajolet M, Cenci MA, Friedman E, Rebholz H.
    J Neurosci; 2017 Dec 06; 37(49):11930-11946. PubMed ID: 29097596
    [Abstract] [Full Text] [Related]

  • 14. Modulation by Trace Amine-Associated Receptor 1 of Experimental Parkinsonism, L-DOPA Responsivity, and Glutamatergic Neurotransmission.
    Alvarsson A, Zhang X, Stan TL, Schintu N, Kadkhodaei B, Millan MJ, Perlmann T, Svenningsson P.
    J Neurosci; 2015 Oct 14; 35(41):14057-69. PubMed ID: 26468205
    [Abstract] [Full Text] [Related]

  • 15. Subregion-Specific Regulation of Dopamine D1 Receptor Signaling in the Striatum: Implication for L-DOPA-Induced Dyskinesia.
    Sugiyama K, Kuroiwa M, Shuto T, Ohnishi YN, Kawahara Y, Miyamoto Y, Fukuda T, Nishi A.
    J Neurosci; 2021 Jul 28; 41(30):6388-6414. PubMed ID: 34131032
    [Abstract] [Full Text] [Related]

  • 16. Buspirone anti-dyskinetic effect is correlated with temporal normalization of dysregulated striatal DRD1 signalling in L-DOPA-treated rats.
    Azkona G, Sagarduy A, Aristieta A, Vazquez N, Zubillaga V, Ruíz-Ortega JA, Pérez-Navarro E, Ugedo L, Sánchez-Pernaute R.
    Neuropharmacology; 2014 Apr 28; 79():726-37. PubMed ID: 24333147
    [Abstract] [Full Text] [Related]

  • 17. Activation of DREAM (downstream regulatory element antagonistic modulator), a calcium-binding protein, reduces L-DOPA-induced dyskinesias in mice.
    Ruiz-DeDiego I, Mellstrom B, Vallejo M, Naranjo JR, Moratalla R.
    Biol Psychiatry; 2015 Jan 15; 77(2):95-105. PubMed ID: 24857398
    [Abstract] [Full Text] [Related]

  • 18. Evidence for a role for α6(∗) nAChRs in l-dopa-induced dyskinesias using Parkinsonian α6(∗) nAChR gain-of-function mice.
    Bordia T, McGregor M, McIntosh JM, Drenan RM, Quik M.
    Neuroscience; 2015 Jun 04; 295():187-97. PubMed ID: 25813704
    [Abstract] [Full Text] [Related]

  • 19. Selective activation of striatal indirect pathway suppresses levodopa induced-dyskinesias.
    Castela I, Casado-Polanco R, Rubio YV, da Silva JA, Marquez R, Pro B, Moratalla R, Redgrave P, Costa RM, Obeso J, Hernandez LF.
    Neurobiol Dis; 2023 Jan 04; 176():105930. PubMed ID: 36414182
    [Abstract] [Full Text] [Related]

  • 20. Striatal Nurr1 Facilitates the Dyskinetic State and Exacerbates Levodopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease.
    Sellnow RC, Steece-Collier K, Altwal F, Sandoval IM, Kordower JH, Collier TJ, Sortwell CE, West AR, Manfredsson FP.
    J Neurosci; 2020 Apr 29; 40(18):3675-3691. PubMed ID: 32238479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.